More deals ahead for Bris­tol My­ers? CEO Gio­van­ni Caforio touts 'size ag­nos­tic' BD strat­e­gy

De­spite gener­ics eat­ing away at one of Bris­tol My­ers Squibb’s high­est sell­ers last year, Revlim­id, CEO Gio­van­ni Caforio main­tained on Wednes­day’s Q2 call that the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER